Literature DB >> 36138349

Colostomy as a definitive treatment in an ALS patient with acute colonic Pseudo-obstruction refractory to medical management, a case report.

Guanghao Liu1, Jennifer Hrabe2, Rolando Sanchez3.   

Abstract

BACKGROUND: Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease, and ALS patients may experience disturbed gastrointestinal motility often resulting in acute colonic pseudo-obstruction (ACPO). There is currently a paucity in the literature to guide the treatment of patients with both ALS and ACPO. CASE
PRESENTATION: Here we describe a 39-year-old male patient with advanced ALS who developed ACPO. His condition was refractory to both medical and procedural managements including polyethylene glycol, senna, and docusate suppository, metoclopramide, linaclotide, erythromycin, prucalopride, neostigmine, and repeated colonoscopies. He ultimately underwent successful colostomy for palliation. Here we report the peri-operative multidisciplinary approach taken with this case, the surgical procedures, the potential risks, and the outcome.
CONCLUSION: The patient is delighted with the result and requested publication of this case to raise awareness of constipation in ALS patients and promote the consideration of colostomy as a treatment option for patients with ileus resistant to conservative management. Ultimately, a multidisciplinary team approach is required to properly assess the risks and benefits to achieve good clinical outcomes.
© 2022. The Author(s).

Entities:  

Keywords:  ALS; Acute colonic pseudo-obstruction; Colostomy

Year:  2022        PMID: 36138349     DOI: 10.1186/s12883-022-02893-x

Source DB:  PubMed          Journal:  BMC Neurol        ISSN: 1471-2377            Impact factor:   2.903


  11 in total

Review 1.  Amyotrophic lateral sclerosis.

Authors:  L P Rowland; N A Shneider
Journal:  N Engl J Med       Date:  2001-05-31       Impact factor: 91.245

2.  Management of postcaesarian Ogilvie's syndrome and their subsequent outcomes.

Authors:  Charlotte Rawlings
Journal:  Aust N Z J Obstet Gynaecol       Date:  2010-09-20       Impact factor: 2.100

3.  Neostigmine: an alternative treatment for constipation.

Authors:  Anne Fu
Journal:  Dynamics       Date:  2005

4.  Delayed colonic transit times in amyotrophic lateral sclerosis assessed with radio-opaque markers.

Authors:  M Toepfer; M Schroeder; A Klauser; H Lochmüller; M Hirschmann; R L Riepl; D Pongratz; W Müller-Felber
Journal:  Eur J Med Res       Date:  1997-11-28       Impact factor: 2.175

5.  Bowel, bladder, and sudomotor symptoms in ALS patients.

Authors:  Verena C Samara; Patricia Jerant; Summer Gibson; Mark Bromberg
Journal:  J Neurol Sci       Date:  2021-06-17       Impact factor: 3.181

Review 6.  Prognostic factors in ALS: A critical review.

Authors:  Adriano Chiò; Giancarlo Logroscino; Orla Hardiman; Robert Swingler; Douglas Mitchell; Ettore Beghi; Bryan G Traynor
Journal:  Amyotroph Lateral Scler       Date:  2009 Oct-Dec

Review 7.  Global epidemiology of amyotrophic lateral sclerosis: a systematic review of the published literature.

Authors:  A Chiò; G Logroscino; B J Traynor; J Collins; J C Simeone; L A Goldstein; L A White
Journal:  Neuroepidemiology       Date:  2013-07-11       Impact factor: 3.282

Review 8.  Gastrointestinal dysfunction in amyotrophic lateral sclerosis.

Authors:  M Toepfer; C Folwaczny; A Klauser; R L Riepl; W Müller-Felber; D Pongratz
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  1999-12

9.  Autonomic nervous disorder in motor neuron disease: a study of advanced stage patients.

Authors:  K Sato; R Namba; T Hayabara; K Kashihara; K Morimoto
Journal:  Intern Med       Date:  1995-10       Impact factor: 1.271

10.  Gallstone ileus in a patient with amyotrophic lateral sclerosis: A case report.

Authors:  Vincent Marcucci; Sindi Diko; Derick Christian
Journal:  Int J Surg Case Rep       Date:  2021-01-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.